Varicose veins research from The Whiteley Clinic is being presented in the USA this week.
Prof Mark Whiteley and Harry Ashpitel, his PhD student, were both presenting at the American College of Phlebology meeting.
Mark started off by being a guest on a panel of vein experts on Thursday 3rd November. He was involved in a one hour session called:
“Testing The Waters: The Scientific Method Applied to Superficial Venous Disease”.
The session was chaired by Dr Steve Elias who had developed an approach as to which veins should be treated by which techniques. The other exerts involved on the panel were Professor Mark Meissner (Seattle), Antonios P. Gasparis (New York) and Melvin Rosenblatt (Fairfield).
The event was run by Vascular Insights who make the Clarivein device for treating varicose veins without injecting “tumescence” – ie: is less painful.
Harry Ashpitel gave his lecture on his specialist area of varicose veins research. Using very specialist techniques such as immunohistochemistry, Harry showed the difference between two commonly used lasers.
He showed the difference between endovenous laser ablation of varicose veins using the 810 nm laser and endovenous laser ablation of varicose veins using the 1470 nm laser.
His research was very well received as only one other research group in the world is looking at anything like this in varicose vein research.
Finally Prof Mark Whiteley presented a poster presentation on behalf of his team. This research has shown that treating pelvic varicose veins under local anaesthetic as a walk in, walk out procedure is both safe and effective.
The Whiteley Clinic has a specialist pelvic vein unit in their Bond Street clinic, in London, that specialises in this pelvic vein embolisation technique.
The research showed the last two years of pelvic vein embolisation treatment which has all been performed under local anaesthetic. Prior to that, they had built up their experience under sedation in hospital over the previous 14 years.
It is only by continually researching our techniques and results that we are able to make sure that patients treated at The Whiteley Clinic, using the Whiteley Protocol, get the very latest and best investigations and treatments possible.
We have always had a commitment to research, but thanks to 2 sets of funding from Innovate UK in the last two years, The Whiteley Clinic now has a dedicated research and development unit headed by Dr Jaya Nemchand.
This dedicated unit will enable The Whiteley Clinic to not only continue being one of the world leading clinics for varicose veins research, but will allow us to increase our research output and move into developing new devices and investigations.